These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 12530612)

  • 1. Elevated monocyte chemotactic protein-1 in amniotic fluid is a risk factor for pregnancy loss.
    Chaiworapongsa T; Romero R; Tolosa JE; Yoshimatsu J; Espinoza J; Kim YM; Kim JC; Bujold E; Kalache K; Edwin S
    J Matern Fetal Neonatal Med; 2002 Sep; 12(3):159-64. PubMed ID: 12530612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An elevated amniotic fluid matrix metalloproteinase-8 level at the time of mid-trimester genetic amniocentesis is a risk factor for spontaneous preterm delivery.
    Yoon BH; Oh SY; Romero R; Shim SS; Han SY; Park JS; Jun JK
    Am J Obstet Gynecol; 2001 Nov; 185(5):1162-7. PubMed ID: 11717651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocyte chemotactic protein-1 is increased in the amniotic fluid of women who deliver preterm in the presence or absence of intra-amniotic infection.
    Esplin MS; Romero R; Chaiworapongsa T; Kim YM; Edwin S; Gomez R; Mazor M; Adashi EY
    J Matern Fetal Neonatal Med; 2005 Jun; 17(6):365-73. PubMed ID: 16009638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated amniotic fluid ferritin levels are associated with inflammation-related pregnancy loss following mid-trimester amniocentesis.
    Ramsey PS; Andrews WW; Goldenberg RL; Tamura T; Wenstrom KD; Johnston KE
    J Matern Fetal Neonatal Med; 2002 May; 11(5):302-6. PubMed ID: 12389670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia.
    Park CW; Park JS; Shim SS; Jun JK; Yoon BH; Romero R
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):984-9. PubMed ID: 16157098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated mid-trimester amniotic fluid ADAM-8 concentrations as a potential risk factor for preterm delivery.
    Vrachnis N; Malamitsi-Puchner A; Samoli E; Botsis D; Iliodromiti Z; Baka S; Hassiakos D; Creatsas G
    J Soc Gynecol Investig; 2006 Apr; 13(3):186-90. PubMed ID: 16638589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated second trimester amniotic fluid interferon gamma-inducible T-cell alpha chemoattractant concentrations as a possible predictor of preterm birth.
    Malamitsi-Puchner A; Vrachnis N; Samoli E; Baka S; Hassiakos D; Creatsas G
    J Soc Gynecol Investig; 2006 Jan; 13(1):25-9. PubMed ID: 16378910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amniotic fluid levels of immunoreactive monocyte chemotactic protein-1 increase during term parturition.
    Esplin MS; Romero R; Chaiworapongsa T; Kim YM; Edwin S; Gomez R; Gonzalez R; Adashi EY
    J Matern Fetal Neonatal Med; 2003 Jul; 14(1):51-6. PubMed ID: 14563093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for procedure-related fetal losses after mid-trimester genetic amniocentesis.
    Kong CW; Leung TN; Leung TY; Chan LW; Sahota DS; Fung TY; Lau TK
    Prenat Diagn; 2006 Oct; 26(10):925-30. PubMed ID: 16838383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy outcome following second-trimester amniocentesis: a case-control study.
    Müngen E; Tütüncü L; Muhcu M; Yergök YZ
    Am J Perinatol; 2006 Jan; 23(1):25-30. PubMed ID: 16450269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual risk of fetal loss following routine second trimester amniocentesis: a controlled study of 20,460 cases.
    Kozlowski P; Knippel A; Stressig R
    Ultraschall Med; 2008 Apr; 29(2):165-72. PubMed ID: 17602371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronan modulates pro-inflammatory immune activity in the mid-trimester amniotic cavity.
    Sezen D; Perni U; Herway C; Bongiovanni AM; Skupski D; Witkin SS
    J Reprod Immunol; 2009 Oct; 82(1):89-93. PubMed ID: 19671477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic mid trimester amniocentesis: how safe?
    Seeds JW
    Am J Obstet Gynecol; 2004 Aug; 191(2):607-15. PubMed ID: 15343248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal loss rate after second trimester amniocentesis at different gestational age.
    Saltvedt S; Almström H
    Acta Obstet Gynecol Scand; 1999 Jan; 78(1):10-4. PubMed ID: 9926885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mid-trimester amniotic fluid C-reactive protein, ferritin and lactate dehydrogenase concentrations and subsequent risk of spontaneous preterm labour.
    Borna S; Mirzaie F; Abdollahi A
    Aust N Z J Obstet Gynaecol; 2009 Aug; 49(4):400-3. PubMed ID: 19694695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amniotic fluid urocortin, CRF, oestriol, dehydroepiandrosterone sulfate and cortisol concentrations at mid-trimester: putative relationship with preterm delivery.
    Torricelli M; Voltolini C; Galleri L; Biliotti G; Giovannelli A; De Bonis M; De Pascalis F; Centini G; Petraglia F
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):169-73. PubMed ID: 19619932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revisiting the fetal loss rate after second-trimester genetic amniocentesis: a single center's 16-year experience.
    Odibo AO; Gray DL; Dicke JM; Stamilio DM; Macones GA; Crane JP
    Obstet Gynecol; 2008 Mar; 111(3):589-95. PubMed ID: 18310360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clara cell protein 16 concentration in mid-trimester amniotic fluid: association with fetal gender, fetal G>A +38 CC16 gene polymorphism and pregnancy outcome.
    Perni SC; Vardhana S; Kalish R; Chasen S; Witkin SS
    J Reprod Immunol; 2005 Dec; 68(1-2):85-90. PubMed ID: 16236364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mid-trimester amniocentesis and antibiotic prophylaxis.
    Gramellini D; Fieni S; Casilla G; Raboni S; Nardelli GB
    Prenat Diagn; 2007 Oct; 27(10):956-9. PubMed ID: 17607664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase 3 in parturition, premature rupture of the membranes, and microbial invasion of the amniotic cavity.
    Park KH; Chaiworapongsa T; Kim YM; Espinoza J; Yoshimatsu J; Edwin S; Gomez R; Yoon BH; Romero R
    J Perinat Med; 2003; 31(1):12-22. PubMed ID: 12661139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.